Cargando…
Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax
BACKGROUND & OBJECTIVES: Anthrax caused by Bacillus anthracis is primarily a disease of herbivorous animals, although several mammals are vulnerable to it. ELISA is the most widely accepted serodiagnostic assay for large scale surveillance of cutaneous anthrax. The aims of this study were to dev...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613441/ https://www.ncbi.nlm.nih.gov/pubmed/26354217 http://dx.doi.org/10.4103/0971-5916.164258 |
_version_ | 1782396278751100928 |
---|---|
author | Ghosh, N. Gunti, D. Lukka, H. Reddy, B.R. Padmaja, Jyothi Goel, A.K. |
author_facet | Ghosh, N. Gunti, D. Lukka, H. Reddy, B.R. Padmaja, Jyothi Goel, A.K. |
author_sort | Ghosh, N. |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Anthrax caused by Bacillus anthracis is primarily a disease of herbivorous animals, although several mammals are vulnerable to it. ELISA is the most widely accepted serodiagnostic assay for large scale surveillance of cutaneous anthrax. The aims of this study were to develop and evaluate a quantitative ELISA for determination of IgG antibodies against B. anthracis protective antigen (PA) in human cutaneous anthrax cases. METHODS: Quantitative ELISA was developed using the recombinant PA for coating and standard reference serum AVR801 for quantification. A total of 116 human test and control serum samples were used in the study. The assay was evaluated for its precision, accuracy and linearity. RESULTS: The minimum detection limit and lower limit of quantification of the assay for anti-PA IgG were 3.2 and 4 µg/ml, respectively. The serum samples collected from the anthrax infected patients were found to have anti-PA IgG concentrations of 5.2 to 166.3 µg/ml. The intra-assay precision per cent CV within an assay and within an operator ranged from 0.99 to 7.4 per cent and 1.7 to 3.9 per cent, respectively. The accuracy of the assay was high with a per cent error of 6.5 - 24.1 per cent. The described assay was found to be linear between the range of 4 to 80 ng/ml (R(2)=0.9982; slope=0.9186; intercept = 0.1108). INTERPRETATION & CONCLUSIONS: The results suggested that the developed assay could be a useful tool for quantification of anti-PA IgG response in human after anthrax infection or vaccination. |
format | Online Article Text |
id | pubmed-4613441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46134412015-11-24 Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax Ghosh, N. Gunti, D. Lukka, H. Reddy, B.R. Padmaja, Jyothi Goel, A.K. Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Anthrax caused by Bacillus anthracis is primarily a disease of herbivorous animals, although several mammals are vulnerable to it. ELISA is the most widely accepted serodiagnostic assay for large scale surveillance of cutaneous anthrax. The aims of this study were to develop and evaluate a quantitative ELISA for determination of IgG antibodies against B. anthracis protective antigen (PA) in human cutaneous anthrax cases. METHODS: Quantitative ELISA was developed using the recombinant PA for coating and standard reference serum AVR801 for quantification. A total of 116 human test and control serum samples were used in the study. The assay was evaluated for its precision, accuracy and linearity. RESULTS: The minimum detection limit and lower limit of quantification of the assay for anti-PA IgG were 3.2 and 4 µg/ml, respectively. The serum samples collected from the anthrax infected patients were found to have anti-PA IgG concentrations of 5.2 to 166.3 µg/ml. The intra-assay precision per cent CV within an assay and within an operator ranged from 0.99 to 7.4 per cent and 1.7 to 3.9 per cent, respectively. The accuracy of the assay was high with a per cent error of 6.5 - 24.1 per cent. The described assay was found to be linear between the range of 4 to 80 ng/ml (R(2)=0.9982; slope=0.9186; intercept = 0.1108). INTERPRETATION & CONCLUSIONS: The results suggested that the developed assay could be a useful tool for quantification of anti-PA IgG response in human after anthrax infection or vaccination. Medknow Publications & Media Pvt Ltd 2015-08 /pmc/articles/PMC4613441/ /pubmed/26354217 http://dx.doi.org/10.4103/0971-5916.164258 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms |
spellingShingle | Original Article Ghosh, N. Gunti, D. Lukka, H. Reddy, B.R. Padmaja, Jyothi Goel, A.K. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax |
title | Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax |
title_full | Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax |
title_fullStr | Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax |
title_full_unstemmed | Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax |
title_short | Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax |
title_sort | development & validation of a quantitative anti-protective antigen igg enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613441/ https://www.ncbi.nlm.nih.gov/pubmed/26354217 http://dx.doi.org/10.4103/0971-5916.164258 |
work_keys_str_mv | AT ghoshn developmentvalidationofaquantitativeantiprotectiveantigeniggenzymelinkedimmunosorbentassayforserodiagnosisofcutaneousanthrax AT guntid developmentvalidationofaquantitativeantiprotectiveantigeniggenzymelinkedimmunosorbentassayforserodiagnosisofcutaneousanthrax AT lukkah developmentvalidationofaquantitativeantiprotectiveantigeniggenzymelinkedimmunosorbentassayforserodiagnosisofcutaneousanthrax AT reddybr developmentvalidationofaquantitativeantiprotectiveantigeniggenzymelinkedimmunosorbentassayforserodiagnosisofcutaneousanthrax AT padmajajyothi developmentvalidationofaquantitativeantiprotectiveantigeniggenzymelinkedimmunosorbentassayforserodiagnosisofcutaneousanthrax AT goelak developmentvalidationofaquantitativeantiprotectiveantigeniggenzymelinkedimmunosorbentassayforserodiagnosisofcutaneousanthrax |